Format

Send to

Choose Destination
Haematologica. 2015 Jun;100(6):e240-3. doi: 10.3324/haematol.2014.119214. Epub 2015 Feb 14.

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.

Author information

1
National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Faculty of Medicine, University of Oslo, Norway knusme@ous-hf.no.
2
National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway.
3
Department of Oncology, Oslo University Hospital, Norway.
4
Department of Oncology, St. Olavs Hospital, Trondheim, Norway Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
5
Oslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Norway.
6
Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
7
National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Department of Behavioural Sciences in Medicine, Faculty of Medicine, University of Oslo, Norway.
8
Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
9
Faculty of Medicine, University of Oslo, Norway Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Norway.

KEYWORDS:

autologous stem cell transplantation; high-dose therapy; mortality; non-Hodgkin lymphoma; survival

PMID:
25682605
PMCID:
PMC4450639
DOI:
10.3324/haematol.2014.119214
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central Icon for Norwegian BIBSYS system
Loading ...
Support Center